Principal Financial Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,649
| Closed | -$208K | – | 2467 |
|
|
2024
Q1 | $208K | Buy |
15,649
+285
| +2% | +$3.79K | ﹤0.01% | 2171 |
|
|
2023
Q4 | $214K | Sell |
15,364
-1,483
| -9% | -$20.7K | ﹤0.01% | 2152 |
|
|
2023
Q3 | $223K | Buy |
16,847
+2,566
| +18% | +$34K | ﹤0.01% | 2133 |
|
|
2023
Q2 | $268K | Buy |
14,281
+509
| +4% | +$9.54K | ﹤0.01% | 2103 |
|
|
2023
Q1 | $199K | Buy |
13,772
+1,364
| +11% | +$19.7K | ﹤0.01% | 2183 |
|
|
2022
Q4 | $240K | Buy |
12,408
+1,883
| +18% | +$36.4K | ﹤0.01% | 2154 |
|
|
2022
Q3 | $361K | Buy |
+10,525
| New | +$361K | ﹤0.01% | 2032 |
|
|
2022
Q1 | – | Sell |
-5,740
| Closed | -$212K | – | 2603 |
|
|
2021
Q4 | $212K | Buy |
+5,740
| New | +$212K | ﹤0.01% | 2344 |
|